Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

Dopaminergic medicines used in the treatment of parkinson’s disease: Risk of Dopamine dysregulation syndrome

File Type: pdf
Categories: Communication To Health Care Professionals
Tags: Pharmacovigilance